Accelerate Diagnostics, Inc.

    Jurisdiction
    United States
    LEI
    2549007HE5QY1QEQ8K43
    ISIN
    US00430H2013 (AXDX)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €10.08M
    Gross margin
    23.1%
    EBIT
    -€30.42M
    EBIT margin
    -301.9%
    Net income
    -€43.12M
    Net margin
    -427.8%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Products

    Product Revenue
    Product €10.22M 101.4%
    Service €1.48M 14.7%
    Product And Service, Other -€33.00K -0.3%

    Earnings Calls

    Latest earnings call: May 8, 2024

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 64K $45.00K -43K Sell

    Add to watchlist

    Notifications